{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:18:47Z","timestamp":1783685927214,"version":"3.55.0"},"reference-count":41,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>We are writing this letter to respond to the letter to the editor regarding the comments that were raised [...]<\/jats:p>","DOI":"10.3390\/ijms27146166","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T11:43:34Z","timestamp":1783683814000},"page":"6166","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reply to Trela, B.A.; Guffroy, M.R. Comment on \u201cAlAsmari et al. Venetoclax Induces Cardiotoxicity Through Modulation of Oxidative-Stress-Mediated Cardiac Inflammation and Apoptosis via NF-\u03baB and BCL-2 Pathway. Int. J. Mol. Sci. 2022, 23, 6260\u201d"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7569-4287","authenticated-orcid":false,"given":"Abdullah F.","family":"AlAsmari","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 55760, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9255-8834","authenticated-orcid":false,"given":"Adel","family":"Alghamdi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 55760, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6525-4202","authenticated-orcid":false,"given":"Nemat","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 55760, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2382-5892","authenticated-orcid":false,"given":"Fawaz","family":"Alasmari","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 55760, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Trela, B.A., and Guffroy, M.R. (2026). Comment on AlAsmari et al. Venetoclax Induces Cardiotoxicity through Modulation of Oxidative-Stress-Mediated Cardiac Inflammation and Apoptosis via NF-\u03baB and BCL-2 Pathway. Int. J. Mol. Sci. 2022, 23, 6260. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms23116260"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1158\/1078-0432.CCR-17-3761","article-title":"Comprehensive Safety Analysis of Venetoclax Monotherapy for Patients with Relapsed\/Refractory Chronic Lymphocytic Leukemia","volume":"24","author":"Davids","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_3","first-page":"A11835","article-title":"Abstract 11835: Evaluation of Cardiovascular Adverse Events Associated with Ibrutinib, Venetoclax and Idelalisib Used in Treatment of Chronic Lymphocytic Leukemia","volume":"138","author":"Mahida","year":"2018","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/ckj\/sfy026","article-title":"Renal involvement in chronic lymphocytic leukemia","volume":"11","author":"Wanchoo","year":"2018","journal-title":"Clin. Kidney J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood-2021-149704","article-title":"Cardiac Events in Patients with Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents","volume":"138","author":"Johnson","year":"2021","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1182\/bloodadvances.2022007333","article-title":"Cardiac events in patients with acute myeloid leukemia treated with venetoclax combined with hypomethylating agents","volume":"6","author":"Johnson","year":"2022","journal-title":"Blood Adv."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijcard.2021.10.011","article-title":"Cardiovascular complications associated with novel agents in the chronic lymphocytic leukemia armamentarium: A pharmacovigilance analysis","volume":"344","author":"Grewal","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"C45","DOI":"10.1152\/ajpcell.00229.2006","article-title":"Bcl-2 family members and apoptosis, taken to heart","volume":"292","author":"Gustafsson","year":"2007","journal-title":"Am. J. Physiol. Physiol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ma, W., Wei, S., Zhang, B., and Li, W. (2020). Molecular Mechanisms of Cardiomyocyte Death in Drug-Induced Cardiotoxicity. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00434"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2015.2","article-title":"DNA damage and the balance between survival and death in cancer biology","volume":"16","author":"Roos","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1089\/ars.2012.4905","article-title":"Regulation of the intrinsic apoptosis pathway by reactive oxygen species","volume":"19","author":"Wu","year":"2013","journal-title":"Antioxidants Redox Signal."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Xia, P., Liu, Y., and Cheng, Z. (2016). Signaling Pathways in Cardiac Myocyte Apoptosis. BioMed Res. Int., 2016.","DOI":"10.1155\/2016\/9583268"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1038\/sj.onc.1209608","article-title":"Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy","volume":"25","author":"Fulda","year":"2006","journal-title":"Oncogene"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3722","article-title":"Control of apoptosis by the BCL-2 protein family: Implications for physiology and therapy","volume":"15","author":"Czabotar","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/1521-2254(200009\/10)2:5<326::AID-JGM133>3.0.CO;2-1","article-title":"Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia\/reperfusion injury","volume":"2","author":"Lambert","year":"2000","journal-title":"J. Gene Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"H2313","DOI":"10.1152\/ajpheart.2001.280.5.H2313","article-title":"Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I\/R injury in transgenic mice","volume":"280","author":"Chen","year":"2001","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/01.RES.0000143898.67182.4c","article-title":"Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia\/reperfusion injury","volume":"95","author":"Imahashi","year":"2004","journal-title":"Circ. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1172\/JCI122533","article-title":"PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas","volume":"128","author":"Ren","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41419-019-2113-0","article-title":"Correction: Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity","volume":"10","author":"Guo","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Lai, C.-C., Tang, C.-Y., Fu, S.-K., Tseng, W.-C., and Tseng, K.-W. (2022). Effects of swimming training on myocardial protection in rats. Biomed. Rep., 16.","DOI":"10.3892\/br.2022.1502"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7150\/ijms.22591","article-title":"Receptor for activated C kinase 1 in rats with ischemia-reperfusion injury: Intravenous versus inhalation anaesthetic agents","volume":"15","author":"Seo","year":"2018","journal-title":"Int. J. Med Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2119\/molmed.2014.00057","article-title":"Reduction of cardiac cell death after helium postconditioning in rats: Transcriptional analysis of cell death and survival pathways","volume":"20","author":"Oei","year":"2015","journal-title":"Mol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.RES.83.6.594","article-title":"Expression of proto-oncogenes and gene mutation of sarcomeric proteins in patients with hypertrophic cardiomyopathy","volume":"83","author":"Kai","year":"1998","journal-title":"Circ. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cardiores.2007.06.022","article-title":"Functional, structural and molecular aspects of diastolic heart failure in the diabetic (mRen-2)27 rat","volume":"76","author":"Connelly","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Wang, K.C., Brooks, D.A., Botting, K.J., and Morrison, J.L. (2012). IGF-2R-mediated signaling results in hypertrophy of cultured cardiomyocytes from fetal sheep. Biol. Reprod., 86.","DOI":"10.1095\/biolreprod.112.100388"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Yuen, D.A., Connelly, K.A., Advani, A., Liao, C., Kuliszewski, M.A., Trogadis, J., Thai, K., Advani, S.L., Zhang, Y., and Kelly, D.J. (2010). Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009543"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.carpath.2017.05.003","article-title":"Exercise training ameliorates matrix metalloproteinases 2 and 9 messenger RNA expression and mitigates adverse left ventricular remodeling in streptozotocin-induced diabetic rats","volume":"29","author":"Silva","year":"2017","journal-title":"Cardiovasc. Pathol."},{"key":"ref_28","first-page":"139","article-title":"Writing group on behalf of the participating experts of the WHO consultation for revision of WHO definition of myocardial infarction World Health Organization definition of myocardial infarction: 2008-09 revision","volume":"40","author":"Mendis","year":"2011","journal-title":"Leuk. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/VHRM.S166157","article-title":"Biomarkers in acute myocardial infarction: Current perspectives","volume":"15","author":"Aydin","year":"2019","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","article-title":"Third Universal Definition of Myocardial Infarction","volume":"126","author":"Thygesen","year":"2012","journal-title":"Circulation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"15059","DOI":"10.1038\/cddiscovery.2015.59","article-title":"Selective cytoprotective effect of histamine on doxorubicin-induced hepatic and cardiac toxicity in animal models","volume":"1","author":"Lamas","year":"2015","journal-title":"Cell Death Discov."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3109\/00498254.2015.1034223","article-title":"Protective effects of berberine against doxorubicin-induced cardiotoxicity in rats by inhibiting metabolism of doxorubicin","volume":"45","author":"Hao","year":"2015","journal-title":"Xenobiotica"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3892\/mmr.2021.12342","article-title":"Canagliflozin is a potential cardioprotective drug but exerts no significant effects on pirarubicin-induced cardiotoxicity in rats","volume":"24","author":"Shi","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1159\/000480471","article-title":"Oxymatrine Ameliorates Doxorubicin-Induced Cardiotoxicity in Rats","volume":"43","author":"Zhang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12012-019-09547-4","article-title":"Coenzyme Q10 Cardioprotective Effects Against Doxorubicin-Induced Cardiotoxicity in Wistar Rat","volume":"20","author":"Botelho","year":"2020","journal-title":"Cardiovasc. Toxicol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12012-015-9356-5","article-title":"Rutin Attenuates Carfilzomib-Induced Cardiotoxicity Through Inhibition of NF-\u03baB, Hypertrophic Gene Expression and Oxidative Stress","volume":"17","author":"Imam","year":"2017","journal-title":"Cardiovasc. Toxicol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Shoukry, H.S., Ammar, H.I., Rashed, L.A., Zikri, M.B., Shamaa, A.A., Elfadl, S.G.A., Rub, E.A.-A., Saravanan, S., and Dhingra, S. (2017). Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181535"},{"key":"ref_38","first-page":"27","article-title":"Molecular and cellular mechanisms of cardiotoxicity","volume":"109","author":"Kang","year":"2001","journal-title":"Environ. Health Perspect."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/path.5192","article-title":"Doxorubicin-induced cardiotoxicity involves IFN\u03b3-mediated metabolic reprogramming in cardiomyocytes","volume":"247","author":"Ni","year":"2019","journal-title":"J. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2353\/ajpath.2007.060906","article-title":"Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic micee","volume":"171","author":"Reifenberg","year":"2007","journal-title":"Am. J. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Ma, P., Qin, Y., Cao, H., Erben, U., Ni, C., and Qin, Z. (2020). Temporary blockade of interferon-\u03b3 ameliorates doxorubicin-induced cardiotoxicity without influencing the anti-tumor effect. Biomed. Pharmacother., 130.","DOI":"10.1016\/j.biopha.2020.110587"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6166\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T11:46:33Z","timestamp":1783683993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":41,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ijms27146166"],"URL":"https:\/\/doi.org\/10.3390\/ijms27146166","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]}}}